nicardipine has been researched along with Migraine Disorders in 10 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A novel calcium entry blocker, nicardipine, has been tested using a dosage of 20 mg twice a day against placebo on 30 patients suffering from migraine without aura, according to a double-blind, cross-over design; overall duration of the study was four months (two with nicardipine and two with placebo)." | 2.67 | Migraine treatment with nicardipine. ( Leandri, M; Parodi, CI; Rigardo, S; Schizzi, R, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 8 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, M | 1 |
| Kumar, AB | 1 |
| Callison, CR | 1 |
| Titus, F | 1 |
| Moltó-Jordà, JM | 1 |
| Matías-Guiu, J | 1 |
| Roquer, J | 1 |
| Cano, A | 1 |
| Pou, A | 1 |
| Shaughnessy, AF | 1 |
| Coria, F | 1 |
| Claveria, LE | 1 |
| Jimenez-Jimenez, FJ | 1 |
| de Seijas, EV | 1 |
| Ordinas, A | 1 |
| Puig-Parellada, P | 1 |
| Planas, JM | 2 |
| Giménez, J | 1 |
| Sánchez, J | 1 |
| Gaya, J | 1 |
| Tolosa, E | 1 |
| Obach, J | 1 |
| Leandri, M | 1 |
| Rigardo, S | 1 |
| Schizzi, R | 1 |
| Parodi, CI | 1 |
| Tuca, JO | 1 |
| Parellada, PP | 1 |
1 review available for nicardipine and Migraine Disorders
| Article | Year |
|---|---|
[Nicardipine and its indications in neurology].
Topics: Brain Ischemia; Calcium Channel Blockers; Dementia; Epilepsy; Humans; Migraine Disorders; Moyamoya D | 1997 |
2 trials available for nicardipine and Migraine Disorders
| Article | Year |
|---|---|
Migraine treatment with nicardipine.
Topics: Blood Pressure; Double-Blind Method; Female; Humans; Male; Migraine Disorders; Nicardipine | 1990 |
Increase in PGE2 and TXA2 in the saliva of common migraine patients. Action of calcium channel blockers.
Topics: Adolescent; Adult; Calcium Channel Blockers; Dinoprostone; Female; Humans; Male; Middle Aged; Migrai | 1989 |
7 other studies available for nicardipine and Migraine Disorders
| Article | Year |
|---|---|
Refractory caffeine and ergot-induced cervico-cerebral vasospasm and stroke treated with combined medical and endovascular approach.
Topics: Adult; Caffeine; Cerebral Angiography; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; | 2012 |
[The treatment of migraine].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; | 1997 |
[Nicardipine and migraine].
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Nicardipine; Prospec | 1997 |
Calcium channel blockers for migraine prophylaxis.
Topics: Calcium Channel Blockers; Evidence-Based Medicine; Humans; Migraine Disorders; Nicardipine | 1999 |
Episodic paroxysmal hemicrania responsive to calcium channel blockers.
Topics: Adult; Calcium Channel Blockers; Female; Flunarizine; Humans; Indomethacin; Male; Middle Aged; Migra | 1992 |
Platelet antiaggregate activity.
Topics: Adenosine Diphosphate; Adolescent; Adult; Arachidonic Acid; Arachidonic Acids; Female; Humans; Male; | 1991 |
Plasma and saliva levels of PGI2 and TXA2 in the headache-free period of classical migraine patients. The effects of nicardipine.
Topics: Adolescent; Adult; Dinoprostone; Female; Humans; Male; Migraine Disorders; Nicardipine; Saliva; Thro | 1991 |